Rovelizumab, CAS [[339086-79-2]]

Produktübersicht

• Artikelname: Rovelizumab, CAS [[339086-79-2]]
• Artikelnummer: TGM-T77166
• Hersteller Artikelnummer: T77166
• Alternativnummer: TGM-T77166-1MG,TGM-T77166-5MG,TGM-T77166-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Hu23F2G

Produktbeschreibung

Rovelizumab (Hu23F2G) is a humanized monoclonal antibody targeting the cell adhesion molecule CD11/CD18. It inhibits overactive leukocytes during shock and may be used in studies of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction, and stroke.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [339086-79-2]
• Target-Kategorie: Integrin|||Complement System